X
NICE’s track record in cancer drugs: the impact of the CDF and interim funding
https://pharmaphorum.com/views-and-analysis/nices-track-record-in-cancer-drugs-the-impact-of-the-cdf-and-interim-funding/
Cancer Drugs Fund
Janssen’s Imbruvica runs into trouble with NICE in mantle cell lymphoma
NICE suggests interim CDF funding while further data is gathered.
NICE close to clearing Cancer Drugs Fund backlog
Only five drugs left to assess from old scheme.
UK funding of cancer drugs: right, wrong, or just plain confused?
How do the countries of the UK fund cancer drugs today, and do they have the right approaches?
Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs Fund
Lilly’s drug will be re-appraised in 2020
NICE backs Amgen’s Blincyto in rare leukaemia
Drug will also be available to children via Cancer Drugs Fund.
